Drug Shortage Report for AMIODARONE HYDROCHLORIDE FOR INJECTION

Last updated on 2023-03-11 History
Report ID 183741
Drug Identification Number 02423227
Brand name AMIODARONE HYDROCHLORIDE FOR INJECTION
Common or Proper name Amiodarone Hydrochloride
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) AMIODARONE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 3 mL vials
ATC code C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-05-15
Actual start date
Estimated end date 2023-06-15
Actual end date 2023-03-07
Shortage status Avoided shortage
Updated date 2023-03-11
Company comments Under allocation
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-03-11 French Compare
v10 2023-03-11 English Compare
v9 2023-02-11 French Compare
v8 2023-02-11 English Compare
v7 2023-02-10 French Compare
v6 2023-02-10 English Compare
v5 2023-02-08 French Compare
v4 2023-02-08 English Compare
v3 2023-02-07 English Compare
v2 2023-02-06 French Compare
v1 2023-02-06 English Compare

Showing 1 to 11 of 11